Quick Overview: At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, a panel of multidisciplinary experts convened to ... In this interview, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, makes predictions on ... John T. Hamm, M.D., Medical Director of the Norton Cancer Institute Research Program, answers the question,
What S Next In Nsclc - Detailed Overview & Context
At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, a panel of multidisciplinary experts convened to ... In this interview, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, makes predictions on ... John T. Hamm, M.D., Medical Director of the Norton Cancer Institute Research Program, answers the question, A panel of multidisciplinary experts convened to discuss optimizing perioperative and neoadjuvant immunotherapy strategies in ... Heather Wakelee, MD, discusses the use of durvalumab after chemoradiotherapy as a new standard in treating stage 3 ... First off, when someone is diagnosed with
Thoracic oncologist Dr. Jyoti Patel explains the basics of non-small cell This video is brought to you by the American Keith Kerr, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, Scotland, discusses
